Third generation oral contraceptive use and cardiovascular risk factors

Author： Doring A. Frohlich M. Lowel H. Koenig W.

Publisher： Elsevier

ISSN： 0021-9150

Source： Atherosclerosis, Vol.172, Iss.2, 2004-02, pp. : 281-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prothrombin 20210A and Oral Contraceptive Use as Risk Factors for Cerebral Venous Thrombosis

Cerebrovascular Diseases, Vol. 19, Iss. 1, 2005-01 ,pp. : 49-52

Karger

Access to resources Recommend Favorite

Oral contraceptive use and measurable cardiovascular risk factors in Korean women aged 20-50 years: The Fourth Korean National Health and Nutrition Examination Survey 2007-2009 (KNHANES IV)

By Lee Jung-Yun

Gynecological Endocrinology, Vol. 29, Iss. 7, 2013-07 ,pp. : 707-711

Informa Healthcare

Access to resources Recommend Favorite

The public warnings on cardiovascular disease and third-generation oral contraceptives were not justified

By Leader Arthur

Human Reproduction, Vol. 11, Iss. 4, 1996-04 ,pp. : 692-693

Oxford University Press

Access to resources Recommend Favorite

Flutamide–metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity

By Ibáñez Lourdes

Human Reproduction, Vol. 19, Iss. 8, 2004-08 ,pp. : 1725-1727

Oxford University Press

Access to resources Recommend Favorite

Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision

By Takamura M. Koga K. Osuga Y. Takemura Y. Hamasaki K. Hirota Y. Yoshino O. Taketani Y.

Human Reproduction, Vol. 24, Iss. 12, 2009-12 ,pp. : 3042-3048

Oxford University Press

Access to resources Recommend Favorite